Barbara Steurer

657 total citations
17 papers, 350 citations indexed

About

Barbara Steurer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Barbara Steurer has authored 17 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Barbara Steurer's work include DNA Repair Mechanisms (5 papers), Genomics and Chromatin Dynamics (5 papers) and RNA modifications and cancer (4 papers). Barbara Steurer is often cited by papers focused on DNA Repair Mechanisms (5 papers), Genomics and Chromatin Dynamics (5 papers) and RNA modifications and cancer (4 papers). Barbara Steurer collaborates with scholars based in Netherlands, Hong Kong and United States. Barbara Steurer's co-authors include Jurgen A. Marteijn, Arjan F. Theil, Roel C. Janssens, Marit E. Geijer, Adriaan B. Houtsmuller, Bart Geverts, Wiggert A. van Cappellen, Joris Pothof, Jiang Chang and Coen Campsteijn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Barbara Steurer

16 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Steurer Netherlands 9 313 34 24 22 17 17 350
Amandine Moretton France 6 290 0.9× 25 0.7× 41 1.7× 21 1.0× 27 1.6× 11 324
Almutasem Saleh United Kingdom 5 296 0.9× 65 1.9× 26 1.1× 12 0.5× 16 0.9× 5 332
Aleksandar Chernev Germany 7 456 1.5× 25 0.7× 40 1.7× 17 0.8× 18 1.1× 13 486
Arijit Dutta United States 11 312 1.0× 81 2.4× 24 1.0× 19 0.9× 43 2.5× 17 343
Vincenzo Di Cerbo United Kingdom 4 296 0.9× 27 0.8× 30 1.3× 10 0.5× 23 1.4× 5 322
Anthony Sanchez United States 10 298 1.0× 59 1.7× 26 1.1× 14 0.6× 30 1.8× 15 361
Laura A. Christensen United States 8 367 1.2× 46 1.4× 34 1.4× 38 1.7× 56 3.3× 11 409
Marco Russo Italy 8 439 1.4× 56 1.6× 17 0.7× 32 1.5× 22 1.3× 17 491
Matthew R. Marunde United States 8 209 0.7× 14 0.4× 29 1.2× 21 1.0× 12 0.7× 10 265
Saulius Lukauskas United Kingdom 6 227 0.7× 60 1.8× 22 0.9× 12 0.5× 17 1.0× 9 248

Countries citing papers authored by Barbara Steurer

Since Specialization
Citations

This map shows the geographic impact of Barbara Steurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Steurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Steurer more than expected).

Fields of papers citing papers by Barbara Steurer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Steurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Steurer. The network helps show where Barbara Steurer may publish in the future.

Co-authorship network of co-authors of Barbara Steurer

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Steurer. A scholar is included among the top collaborators of Barbara Steurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Steurer. Barbara Steurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wang, Wen‐An, Andrea Garofoli, Evandro Ferrada, et al.. (2025). Human genetic variants in SLC39A8 impact uptake and steady-state metal levels within the cell. Life Science Alliance. 8(4). e202403028–e202403028.
2.
Steurer, Barbara, et al.. (2024). MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer. Drug Discovery Today. 29(11). 104189–104189. 4 indexed citations
3.
Steurer, Barbara, Quentin Vanhaelen, & Alex Zhavoronkov. (2024). Multimodal Transformers and Their Applications in Drug Target Discovery for Aging and Age-Related Diseases. The Journals of Gerontology Series A. 79(9). 5 indexed citations
4.
Long, Xi, Barbara Steurer, Владимир Наумов, et al.. (2024). AI-enabled cancer target prioritization with optimal profiles balancing novelty, confidence and commercial tractability. 2(1). 1 indexed citations
5.
Steurer, Barbara, Roel C. Janssens, Di Zhou, et al.. (2024). Differential processing of RNA polymerase II at DNA damage correlates with transcription-coupled repair syndrome severity. Nucleic Acids Research. 52(16). 9596–9612. 9 indexed citations
6.
Meng, Fanye, Jinxin Liu, Zhongying Cao, et al.. (2024). Discovery of macrocyclic CDK2/4/6 inhibitors with improved potency and DMPK properties through a highly efficient macrocyclic drug design platform. Bioorganic Chemistry. 146. 107285–107285. 4 indexed citations
7.
Ding, Xiaoyu, Zhongying Cao, Wei Zhu, et al.. (2024). Discovery of novel MAT2A inhibitors by an allosteric site-compatible fragment growing approach. Bioorganic & Medicinal Chemistry. 100. 117633–117633. 4 indexed citations
8.
Xu, Jianyu, Ling Wang, Barbara Steurer, et al.. (2024). Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 67(10). 8161–8171. 8 indexed citations
9.
Ferrada, Evandro, Tabea Wiedmer, Wen‐An Wang, et al.. (2023). Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8. Journal of Molecular Biology. 436(2). 168383–168383. 6 indexed citations
10.
Steurer, Barbara, Roel C. Janssens, Marit E. Geijer, et al.. (2022). DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II. Nature Communications. 13(1). 3624–3624. 35 indexed citations
11.
Landsverk, Helga B., Barbara Steurer, Coen Campsteijn, et al.. (2020). WDR82/PNUTS-PP1 Prevents Transcription-Replication Conflicts by Promoting RNA Polymerase II Degradation on Chromatin. Cell Reports. 33(9). 108469–108469. 44 indexed citations
12.
Kochan, Jakub, Emilie Desclos, Barbara Steurer, et al.. (2019). Ultra-soft X-ray system for imaging the early cellular responses to X-ray induced DNA damage. Nucleic Acids Research. 47(17). e100–e100. 9 indexed citations
13.
Steurer, Barbara, et al.. (2019). Fluorescently-labelled CPD and 6-4PP photolyases: new tools for live-cell DNA damage quantification and laser-assisted repair. Nucleic Acids Research. 47(7). 3536–3549. 20 indexed citations
14.
Steurer, Barbara, Roel C. Janssens, Bart Geverts, et al.. (2018). Live-cell analysis of endogenous GFP-RPB1 uncovers rapid turnover of initiating and promoter-paused RNA Polymerase II. Proceedings of the National Academy of Sciences. 115(19). E4368–E4376. 144 indexed citations
15.
Steurer, Barbara & Jurgen A. Marteijn. (2016). Traveling Rocky Roads: The Consequences of Transcription-Blocking DNA Lesions on RNA Polymerase II. Journal of Molecular Biology. 429(21). 3146–3155. 23 indexed citations
16.
Cappellen, Wiggert A. van, Barbara Steurer, Timo L.M. ten Hagen, et al.. (2015). C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(8). 1656–1670. 6 indexed citations
17.
Theil, Arjan F., Julie Nonnekens, Barbara Steurer, et al.. (2013). Disruption of TTDA Results in Complete Nucleotide Excision Repair Deficiency and Embryonic Lethality. PLoS Genetics. 9(4). e1003431–e1003431. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026